A Phase I/II Trial of ZD1839 (Iressa) and Rapamycin (Rapamune) in Patients With Advanced Non Small Cell Lung Cancer
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I/II
Latest Information Update:
08 Oct 2012
Price :
$35
*
-
Adis is an information provider.
-
Final gross price and currency may vary according to local VAT and billing address.
-
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
-
A link to download a PDF version of the trial profile will be included in your email receipt.